Noticias de Eulerpool Shanghai Fosun Pharmaceutical Group Co

Shanghai Fosun Pharmaceutical Group Co Eulerpool-AFX

Shanghai Fosun Pharmaceutical Group Co Noticias de Acciones

Shanghai Fosun Pharmaceutical Group Co es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Shanghai Fosun Pharmaceutical Group Co.

• 28 de agosto ·

  Yahoo
  Fosun Pharma Announces 2024 Interim Results
• 26 de abril ·

  Yahoo
  Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
• 8 de marzo ·

  SeekingAlpha
  Fosun Tourism At Crossroads As Parent Shops Its Two Major Assets
• 17 de diciembre ·

  SeekingAlpha
  Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
• 15 de diciembre ·

  Yahoo
  Fosun’s Hospital Arm Weighs $141 Million Funding Round, Sources Say
• 14 de diciembre ·

  Yahoo
  Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
• 12 de noviembre ·

  Yahoo
  Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patients
• 20 de septiembre ·

  Yahoo
  Cevira Phase III trial for non-surgical HSIL treatment meets primary endpoint
• 7 de septiembre ·

  SeekingAlpha
  Debt Pressures Cast Cloud Over Fosun Pharma Results
• 30 de agosto ·

  Yahoo
  Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure